{
  "api": "assay-systems/v1",
  "key_tier": "none",
  "retrieved": "2026-10-16T16:05:02Z",
  "source": "Assay Systems register, https://assay-systems.com/register/",
  "access_notice": "On 15 November 2026, automated access to assay-systems.com closes. After that date, access is available only under a paid annual subscription contract. Contact: contact@assay-systems.com",
  "data": {
    "id": "ASY-CA-113C2HG0BT",
    "type": "grant",
    "country": "ca",
    "name": "Global Fund to Fight AIDS, Tuberculosis & Malaria: federal grants and contributions",
    "url": "https://assay-systems.com/register/ca/grants/r/global-fund-to-fight-aids-tuberculosis-malaria/",
    "summary": "4 federal grant and contribution agreements worth $1.9B with Global Fund to Fight AIDS, Tuberculosis & Malaria, 2017–2021.",
    "figures": [
      {
        "label": "agreements",
        "value": 4,
        "unit": "count"
      },
      {
        "label": "value",
        "value": 1900000000,
        "unit": "money",
        "currency": "CAD",
        "approximate": true,
        "display": "$1.9B"
      },
      {
        "label": "departments",
        "value": 1,
        "unit": "count"
      },
      {
        "label": "programs",
        "value": 1,
        "unit": "count"
      }
    ],
    "text": [
      "This grant represents Canada’s long-term institutional support to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund to Fight AIDS, Tuberculosis and Malaria uses these funds, along with other donors’ funding, to achieve its mandate. The Global Fund to Fight AIDS, Tuberculosis and Malaria is a unique, public-private partnership and international financing institution dedicated to attracting and disbursing additional resources to prevent and treat AIDS, tuberculosis and malaria. It is a partnership between governments, civil society, the private sector and affected communi",
      "Canadian funding through this project will enable the Global Fund to procure and deliver about 6,329,000 antigen rapid diagnostic tests (Ag-RDTs) to low-income and lower middle-income countries (LICs & LMIICs), at the current price of US$2.50 per test. Of this amount, 75% would go to most severely-affected countries in Africa, and most of the remainder going to the hardest-hit countries in Asia. These tests represent a significant improvement over lab-based or automated polymerase chain reaction (PCR) tests, which are being used in a number of countries. Compared with PCR tests, which can be"
    ],
    "records": [
      {
        "name": "grants and contributions register",
        "url": "https://assay-systems.com/register/ca/grants/"
      },
      {
        "name": "Global Affairs Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/global-affairs-canada/"
      }
    ],
    "assay_record": "ASY-CA-113C2HG0BT",
    "cite_as": "Assay Systems, \"Global Fund to Fight AIDS, Tuberculosis & Malaria: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/global-fund-to-fight-aids-tuberculosis-malaria/"
  }
}